GB Sciences, Inc.
GBLX
$0.0002
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -40.29% | 16.24% | -1.95% | 41.12% | 43.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.07% | -4.62% | -15.05% | -0.84% | 3.20% |
| Operating Income | 42.07% | 4.62% | 15.05% | 0.84% | -3.20% |
| Income Before Tax | 71.91% | 64.78% | 66.99% | 22.77% | -4,174.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 71.91% | 64.78% | 66.99% | 22.77% | -4,174.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.91% | 64.78% | 66.99% | 23.70% | -2,514.69% |
| EBIT | 42.07% | 4.62% | 15.05% | 0.84% | -3.20% |
| EBITDA | 41.36% | 1.83% | 11.83% | -4.28% | -6.69% |
| EPS Basic | 74.11% | 59.22% | 62.16% | 30.46% | -3,633.33% |
| Normalized Basic EPS | 21.43% | -12.00% | 9.68% | 31.43% | 33.33% |
| EPS Diluted | 74.11% | 59.22% | 62.16% | 30.46% | -148.89% |
| Normalized Diluted EPS | 21.43% | -12.00% | 9.68% | 31.43% | 31.71% |
| Average Basic Shares Outstanding | 5.64% | 8.39% | 10.92% | 13.83% | 17.32% |
| Average Diluted Shares Outstanding | 5.64% | 8.39% | 10.92% | 13.83% | 15.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |